Last reviewed · How we verify
NCT05626413
Cardiovascular Disease in Patients With Diabetes: The Silesia Diabetes-Heart Project
Status unknown
Last updated 10 April 2024
What this trial tests
trial in Diabetes Mellitus in 4,000 participants. Status unknown.
Timeline
1 January 2015
Primary endpoint
31 December 2025
31 December 2025
31 January 2026
Quick facts
| Lead sponsor | Medical University of Silesia |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 4,000 |
| Start date | 1 January 2015 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 January 2026 |
| Sites | 1 location across Poland |
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Medical University of Silesia
Who can join
18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project is an observational one which undertakes different, easy to obtain in everyday clinical practice, demographical, laboratory and clinical parameters of patients with diabetes in Silesian Region in Poland to predict cardiovascular disease, cardiovascular events and neuropathy using machine learning approach.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Predicting major adverse cardiac events in diabetes and chronic kidney disease: a machine learning study from the Silesia Diabetes-Heart Project.
Kwiendacz H, Huang B, Chen Y, Janota O, et al · · 2025 · cited 12× · PMID 39955553 · DOI 10.1186/s12933-025-02615-w -
Machine Learning Identifies Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Diabetes Mellitus.
Nabrdalik K, Kwiendacz H, Irlik K, Hendel M, et al · · 2024 · cited 12× · PMID 38330228 · DOI 10.1210/clinem/dgae060 -
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project.
Nabrdalik K, Kwiendacz H, Irlik K, Hendel M, et al · · 2023 · cited 11× · PMID 37985994 · DOI 10.1186/s12933-023-02014-z -
Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.
Janota O, Mantovani M, Kwiendacz H, Irlik K, et al · · 2024 · cited 7× · PMID 39227929 · DOI 10.1186/s12933-024-02420-x -
Artificial intelligence-based classification of cardiac autonomic neuropathy from retinal fundus images in patients with diabetes: The Silesia Diabetes Heart Study.
Nabrdalik K, Irlik K, Meng Y, Kwiendacz H, et al · · 2024 · cited 6× · PMID 39127709 · DOI 10.1186/s12933-024-02367-z -
Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project.
Kwiendacz H, Wijata AM, Nalepa J, Piaśnik J, et al · · 2023 · cited 4× · PMID 37620935 · DOI 10.1186/s12933-023-01938-w -
Diabetic kidney disease phenotypes and the risk of cardiovascular events: The Silesia Diabetes-Heart Project.
Janota-Sosińska O, Mantovani M, Irlik K, Kwiendacz H, et al · · 2025 · cited 2× · PMID 40739504 · DOI 10.1186/s12933-025-02852-z -
Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes-Heart Project.
Mantovani M, Kwiendacz H, Irlik K, Bucci T, et al · · 2026 · cited 1× · PMID 40963505 · DOI 10.1111/dme.70136
Verify or expand the search:
- PubMed search for NCT05626413
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Medical University of Silesia trials
Trials by the same sponsor.
- NCT06212674 — Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients · Phase 4 · recruiting
- NCT06970002 — Respiratory Stabilization in Chronic Acidosis Before Bronchofiberoscopy & Non-Invasive Ventilation Effectivenes · NA · not yet recruiting
- NCT07137299 — POPQ Associated With Total Laparoscopic Hysterectomy · not yet recruiting
- NCT06970041 — To Assess the Types of Mechanical Ventilation in Enabling Therapeutic Bronchofiberoscopy in Patients With Decompensated · NA · not yet recruiting
- NCT07120529 — Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT05626413 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Silesia
- Last refreshed: 10 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05626413.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing